SearchDictionaryMobileLogin

Quantitative analysis of amyloid plaques in a mouse model of Alzheimer's disease by phase-contrast X-ray computed tomography.

AbstractDensely aggregated beta-amyloid peptides are believed to play a key role in the pathogenesis of Alzheimer's disease. Amyloid plaques are a potential target for molecular imaging to determine the clinical status of Alzheimer's disease. Phase-contrast X-ray imaging combined with computed tomography is a promising technique that can be used to visualize the physical density of structures in biological tissues non-invasively, and without the use of imaging agents. Using brain tissue isolated from a mouse model of Alzheimer's disease, we show that beta-amyloid 40-positive/beta-amyloid 42-positive amyloid plaques, but not beta-amyloid 40-negative/beta-amyloid 42-positive amyloid plaques, exist as high-density aggregates that can be specifically detected by phase-contrast X-ray computed tomography. The phase-contrast X-ray computed tomography detected beta-amyloid 40-positive/beta-amyloid 42-positive amyloid plaques in three-dimensions with an extremely high sensitivity comparable to that of histological analysis, and also enabled the load of amyloid plaques to be quantified. Furthermore, the use of phase-contrast X-ray computed tomography reveals that the physical density of beta-amyloid 40-positive/beta-amyloid 42-positive amyloid plaques increases with age, and that the large volume, high-density, amyloid plaques that are specifically observed in aged Alzheimer's disease mice are closely associated with neuritic dystrophy. These results demonstrate that phase-contrast X-ray computed tomography is a highly sensitive imaging technique for analyzing dense-cored amyloid plaques in postmortem samples, and is beneficial in elucidating amyloid pathophysiology in Alzheimer's disease.
AuthorsK Noda-Saita, A Yoneyama, Y Shitaka, Y Hirai, K Terai, J Wu, T Takeda, K Hyodo, N Osakabe, T Yamaguchi, M Okada (Affiliation: Neuroscience, Pharmacology Research Laboratories, Drug Discovery Research, Astellas Pharma Inc., 21, Miyukigaoka, Tsukuba, Ibaraki 305-8585, Japan. kyouko.saita at jp.astellas.com)
JournalNeuroscience (Neuroscience) Vol. 138 Issue 4 Pg. 1205-13 ( 2006) ISSN: 0306-4522 United States
PMID16460878 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amyloid beta-Protein
  • Peptide Fragments
  • amyloid beta-protein (1-40)
  • amyloid beta-protein (1-42)
Topics
  • Aging (pathology)
  • Alzheimer Disease (physiopathology, radiography)
  • Amyloid beta-Protein (metabolism)
  • Animals
  • Cerebral Cortex (metabolism, pathology, radiography)
  • Disease Models, Animal
  • Female
  • Mice
  • Mice, Transgenic
  • Microscopy, Phase-Contrast (methods)
  • Neurites (metabolism, pathology)
  • Peptide Fragments (metabolism)
  • Predictive Value of Tests
  • Senile Plaques (metabolism, pathology, radiography)
  • Tomography, X-Ray Computed (methods)